Moreover, our choice of proliferating cell lines, such as leukemia cell lines, may contribute to the observed sensitivity to TOP2 inhibitors, given TOP2’s vital role in DNA replication termination and chromosome segregation during mitosis. The gene discussed is TOP2A; the disease is leukemia.